Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi AppTec Reports Record First-Quarter In 2022 2022-04-25 17:52
WuXi ATU Announces Launch of TESSA™ Technology to Improve Scalability and Accessibility of Cell and Gene Therapies 2022-03-08 08:00
Statement by WuXi AppTec Regarding Recent Market Fluctuation 2021-12-16 08:00
WuXi AppTec Receives 2021 Global Customer Value Leadership Award from Frost & Sullivan 2021-12-09 08:00
WuXi AppTec Receives AA ESG Rating from MSCI 2021-09-06 08:00
WuXi AppTec Reports Strong 2021 Interim Results 2021-08-12 17:52
WuXi AppTec Reports Strong 2020 Annual Results 2021-03-30 21:10
WuXi AppTec Recognized by Frost & Sullivan with 2020 Global Customer Value Leadership Award 2020-12-03 08:00
WuXi AppTec Achieved Strong Growth in First-Half of 2020 with China Sites Resuming Full Operations 2020-08-13 16:49
WuXi AppTec Reports Solid First-Quarter 2020 Results 2020-04-29 17:30
WuXi AppTec Reports Strong 2019 Annual Results 2020-03-24 18:56
WuXi Advanced Therapies Launches New World-Class AAV Vector Suspension Platform 2020-01-13 22:00
WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility 2020-01-03 08:10
WuXi AppTec Receives Investment Grade Corporate Ratings from Three Global Rating Agencies 2019-11-06 16:00
WuXi AppTec Research Service Division and BioSolveIT Introduce GalaXi®, a Vast New Chemical Space of Tangible Molecules 2019-10-11 08:02
WuXi AppTec Reports First Half 2019 Interim Results 2019-08-19 19:20
WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections 2019-07-23 12:48
WuXi AppTec Named One of MIT Technology Review's 50 Smartest Companies 2019-06-29 13:26
1 2